<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250525065880N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-05-29</date_registration>
      <primary_sponsor>Riphah  International  University</primary_sponsor>
      <public_title>Effects of floss banding technique and Instrument-assisted soft tissue mobilization on  Pain, Range of motion in athletes with Achilles tendinopathy</public_title>
      <acronym></acronym>
      <scientific_title>Effects of floss banding technique and Instrument-assisted soft tissue mobilization on  Pain, Range of motion in athletes with Achilles tendinopathy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-08-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>34</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/83831</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants randomly allocated to two groups using sealed envelope method to ensure allocation concealment and biasness reduction. A set of sealed envelop assigned as group A and the other one was group B. Group A was given the Floss band treatment and group B was given the Instrument assisted soft tissue mobilization, Blinding description: Participants were unaware of their allocation. it means that we use envelop method for concealment. we also used sham intervention for participants blinding. we gave a fake treatment of instrument assisted soft tissue mobilization to the FLOSS band group. we did not apply pressure on participants for fake sensation. we did the same procedure to group B of instrument assisted soft tissue mobilization.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Achilles Tendinopathy.</hc_freetext>
      <i_freetext>Intervention 1: In Group A received 12 sessions of floss band over a 6 week period in patients with Achilles tendinopathy. Floss band applied for 2 min after warm up and baseline treatment. Patients were assessed before first session, after 6th session and after 12th session. Warm up with hot pack. Baseline treatment include eccentric exercise 15 repetitions and 3 sets of CALF stretches with 30 seconds hold and then 3sts of  strengthening exercise of calf muscles with 15 repetitions per set. Floss band was applied on ankle joint and Achilles tendon with figure 8 warping method. The floss band was with 7 feet length, 1.1mm thickness and 5cm width. Floss band  overlapped by 50% to extent possible. passive dorsiflexion and planter flexion inversion and eversion performed after wrapping then remove floss bandtervention group:. Intervention 2: Intervention group: Group B recieved 12 sessions of IASTM over a 6-week period in adults with Achilles tendinopathy. Group A received 2 visits treatment per week. IASTM applied for 2 min after 5 min warm up and baseline treatment. Patients were assessed before first session and after 6th session and at the end of follow-up after 12th session. Warm provided with hot pack. Baseline treatment include eccentric exercise 15 repetitions and 3 sets of CALF stretches with 30 seconds hold and then 3sts of  strengthening exercise of calf muscles with 15 repetitions per set. IASTM tool was applied at the angle of 60 degree. IASTM tool was applied parallel to the muscle fibers and tendon.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Inform consent data collection form,  It contain personal information, Contact info

When:
Data will be available  after 4 weeks of study completion.

To whom:
For students' Participants' Rsearchers and teachers

Conditions:
For athletes improvement, For next researches and under
Google scholar and Pubmed

Where to obtain:
Google scholar and Pubmed

How to obtain:
N/A

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Muhammad Hassan Ikhlas</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>PGSHF block D1 house#348 satiana road faisalabad</address>
        <city>Faisalabad</city>
        <country1>Pakistan</country1>
        <zip>38000</zip>
        <telephone>+92 334 4788248</telephone>
        <email>mianhassan896@gmail.com</email>
        <affiliation>Riphah international University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Muhammad Hassan Ikhlas</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Punjab govt servant housing foundation satiana road faisalabad blockD1 House# 348</address>
        <city>Faisalabad</city>
        <country1>Pakistan</country1>
        <zip>38000</zip>
        <telephone>+92 334 4788248</telephone>
        <email>drphysio896@gmail.com</email>
        <affiliation>Riphah international university</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>If patient feel pain in the achilles tendon,
The Victorian Institute of Sport Assessment-Achilles (VISA-A) score less than 78,
Decreased ankle range of motion
Age between 18y to 35y</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Previous achilles tendon surgery
Pain in any other region (knee, hip)
Local infection
If pregnant
Diabetic neuropathy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M67.00</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Short Achilles tendon (acquired), unspecified ankle</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In Group A received 12 sessions of floss band over a 6 week period in patients with Achilles tendinopathy. Floss band applied for 2 min after warm up and baseline treatment. Patients were assessed before first session, after 6th session and after 12th session. Warm up with hot pack. Baseline treatment include eccentric exercise 15 repetitions and 3 sets of CALF stretches with 30 seconds hold and then 3sts of  strengthening exercise of calf muscles with 15 repetitions per set. Floss band was applied on ankle joint and Achilles tendon with figure 8 warping method. The floss band was with 7 feet length, 1.1mm thickness and 5cm width. Floss band  overlapped by 50% to extent possible. passive dorsiflexion and planter flexion inversion and eversion performed after wrapping then remove floss bandtervention group:</i_keyword>
      <i_keyword>Intervention group: Group B recieved 12 sessions of IASTM over a 6-week period in adults with Achilles tendinopathy. Group A received 2 visits treatment per week. IASTM applied for 2 min after 5 min warm up and baseline treatment. Patients were assessed before first session and after 6th session and at the end of follow-up after 12th session. Warm provided with hot pack. Baseline treatment include eccentric exercise 15 repetitions and 3 sets of CALF stretches with 30 seconds hold and then 3sts of  strengthening exercise of calf muscles with 15 repetitions per set. IASTM tool was applied at the angle of 60 degree. IASTM tool was applied parallel to the muscle fibers and tendon</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: Before treatment, after sixth visit and after 12th visit. Method of measurement: Numeric Pain Rating Scale  , The Victorian Institute of Sport Assessment-Achilles Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Range of motion. Timepoint: Before treatment starting, After 6th visit and after 12th visit. Method of measurement: Goniometer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Riphah  International  University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-07-30</approval_date>
        <contact_name>Research &amp; Ethical Review Committee "Riphah College of Rehabilitation and Allied Health Sciences"  R</contact_name>
        <contact_address>25 Raza Saeed Road, Bhabra Block M Gulberg 3, Lahore Pakistan Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
